Rizzo, Alessandro; Monteiro, Fernando Sabino Marques; Ürün, Yüksel; Massari, Francesco; Park, Se Hoon; Bourlon, Maria T; Poprach, Alexandr; Rizzo, Mimma; Takeshita, Hideki; Giannatempo, Patrizia; Soares, Andrey; Roviello, Giandomenico; Molina-Cerrillo, Javier; Carrozza, Francesco; Abahssain, Halima; Messina, Carlo; Kopp, Ray Manneh; Pichler, Renate; Formisano, Luigi; Tural, Deniz; Atzori, Francesco; Calabrò, Fabio; Kanesvaran, Ravindran; Buti, Sebastiano; Santoni, Matteo, Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project, «TARGETED ONCOLOGY», 2024, 1, pp. 1 - 9 [articolo]
Santoni, Matteo; Takeshita, Hideki; Massari, Francesco; Bamias, Aristotelis; Cerbone, Linda; Fiala, Ondrej; Mollica, Veronica; Buti, Sebastiano; Santoni, Angela; Bellmunt, Joaquim, Pembrolizumab plus enfortumab vedotin in urothelial cancer, «NATURE REVIEWS. UROLOGY», 2024, 1, pp. 1 - 2 [articolo]
Rizzo, Mimma; Soares, Andrey; Grande, Enrique; Bamias, Aristotelis; Kopp, Ray Manneh; Lenci, Edoardo; Buttner, Thomas; Salah, Samer; Grillone, Francesco; de Carvalho, Icaro Thiago; Tapia, Jose Carlos; Gucciardino, Calogero; Pinto, Alvaro; Mennitto, Alessia; Abahssain, Halima; Rescigno, Pasquale; Myint, Zin; Takeshita, Hideki; Spinelli, Gian Paolo; Popovic, Lazar; Vitale, Maria Giuseppa; Fiala, Ondrej; Giannatempo, Patrizia; Zakopoulou, Roubini; Carrozza, Francesco; Massari, Francesco; Monteiro, Fernando Sabino Marques; Pace, Maria Paola; Giannini, Massimo; Roviello, Giandomenico; Porta, Camillo; Battelli, Nicola; Kanesvaran, Ravindran; Santoni, Matteo, Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study, «SCIENTIFIC REPORTS», 2024, 14, pp. 1 - 11 [articolo]
Fiala, Ondřej; Buti, Sebastiano; Bamias, Aristotelis; Massari, Francesco; Pichler, Renate; Maruzzo, Marco; Grande, Enrique; De Giorgi, Ugo; Molina-Cerrillo, Javier; Seront, Emmanuel; Calabrò, Fabio; Myint, Zin W; Facchini, Gaetano; Kopp, Ray Manneh; Berardi, Rossana; Kucharz, Jakub; Vitale, Maria Giuseppa; Pinto, Alvaro; Formisano, Luigi; Büttner, Thomas; Messina, Carlo; Monteiro, Fernando Sabino M; Battelli, Nicola; Kanesvaran, Ravindran; Büchler, Tomáš; Kopecký, Jindřich; Santini, Daniele; Giudice, Giulia Claire; Porta, Camillo; Santoni, Matteo, Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study), «TARGETED ONCOLOGY», 2024, 1, pp. 1 - 13 [articolo]Open Access
Santini, Daniele; Li, Haoran; Roviello, Giandomenico; Park, Se Hoon; Grande, Enrique; Kucharz, Jakub; Basso, Umberto; Fiala, Ondrej; Monteiro, Fernando Sabino Marques; Poprach, Alexandr; Buti, Sebastiano; Molina-Cerrillo, Javier; Catalano, Martina; Buchler, Tomas; Seront, Emmanuel; Ansari, Jawaher; Myint, Zin W; Ghosn, Marwan; Calabrò, Fabio; Kopp, Ray Manneh; Bhuva, Dipen; Bourlon, Maria T; Roberto, Michela; Di Civita, Mattia Alberto; Mollica, Veronica; Marchetti, Andrea; Soares, Andrey; Battelli, Nicola; Ricci, Marco; Kanesvaran, Ravindran; Bamias, Aristotelis; Porta, Camillo; Massari, Francesco; Santoni, Matteo, Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1), «TARGETED ONCOLOGY», 2024, 1, pp. 1 - 11 [articolo]
Incorvaia, Lorena; Monteiro, Fernando Sabino Marques; Massari, Francesco; Park, Se Hoon; Roviello, Giandomenico; Fiala, Ondřej; Myint, Zin W; Kucharz, Jakub; Molina-Cerrillo, Javier; Santini, Daniele; Buttner, Thomas; Poprach, Alexandr; Kopecky, Jindrich; Zeppellini, Annalisa; Pichler, Martin; Buchler, Tomas; Pichler, Renate; Facchini, Gaetano; Fay, Andre Poisl; Soares, Andrey; Manneh, Ray; Iezzi, Laura; Kuronya, Zsofia; Russo, Antonio; Bourlon, Maria T; Bhuva, Dipen; Ansari, Jawaher; Kanesvaran, Ravindran; Grande, Enrique; Buti, Sebastiano; Santoni, Matteo, Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2024, 73, pp. 1 - 12 [articolo]Open Access
Vitale, Elsa; Rizzo, Alessandro; Maistrello, Lorenza; Guven, Deniz Can; Massafra, Raffaella; Mollica, Veronica; Monteiro, Fernando Sabino Marques; Santoni, Matteo; Massari, Francesco, Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis, «SCIENTIFIC REPORTS», 2024, 14, pp. 1 - 11 [articolo]Open Access
Mollica, Veronica; Rosellini, Matteo; Brocchi, Stefano; Galuppi, Francesco; Paccapelo, Alexandro; Tateo, Valentina; Marchetti, Andrea; Tassinari, Elisa; Mantuano, Francesco; Santoni, Matteo; Massari, Francesco, Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2024, 9, pp. 17 - 24 [articolo]Open Access
Tassinari, Elisa; Rosellini, Matteo; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco, What is the risk of hepatotoxicity induced by immune-checkpoint inhibitors and how can we avoid it?, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2024, 1, pp. 1 - 4 [articolo]
Nuvola, Giacomo; Santoni, Matteo; Rizzo, Mimma; Rosellini, Matteo; Mollica, Veronica; Rizzo, Alessandro; Marchetti, Andrea; Battelli, Nicola; Massari, Francesco, Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer, «EXPERT REVIEW OF ANTICANCER THERAPY», 2023, 1, pp. 1 - 8 [articolo]
Valentina Tateo; Paola Valeria Marchese; Veronica Mollica; Francesco Massari; Razelle Kurzrock; Jacob J. Adashek, Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics, «PHARMACEUTICALS», 2023, 16, Article number: 614, pp. 1 - 24 [articolo]Open Access
Internò, V; Massari, F; Rudà, R; Maiorano, B A; Caffo, O; Procopio, G; Bracarda, S; Atzori, F; Passarelli, A; Bersanelli, M; Stellato, M; Fornarini, G; Galli, L; Ortega, C; Zanardi, E; Incorvaia, L; Facchini, G; Giron Berrios, J R; Ricotta, R; Santoni, M; Funaioli, C; Trerotoli, P; Porta, C; Rizzo, M, An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study, «ESMO OPEN», 2023, 8, Article number: 101598, pp. 1 - 9 [articolo]Open Access
Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Tateo, Valentina; Nuvola, Giacomo; Rizzo, Alessandro; Massari, Francesco; Mollica, Veronica, An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma, «EXPERT OPINION ON DRUG SAFETY», 2023, 1, pp. 1 - 13 [articolo]
Mollica, Veronica; Massari, Francesco, Belzutifan: enhancing the blockade of angiogenesis in renal cell carcinoma, «THE LANCET ONCOLOGY», 2023, 24, pp. 423 - 425 [articolo]Open Access
Santoni, Matteo; Massari, Francesco; Takeshita, Hideki; Tapia, Jose Carlos; Dionese, Michele; Pichler, Renate; Rizzo, Mimma; Lam, Elaine T; Grande, Enrique; Kemp, Robert; Molina-Cerrillo, Javier; Calabrò, Fabio; Tural, Deniz; Küronya, Zsófia; Kucharz, Jakub; Fiala, Ondrej; Seront, Emmanuel; Kopp, Ray Manneh; Abahssain, Halima; Kopecky, Jindrich; Martignetti, Angelo; Kanesvaran, Ravindran; Zakopoulou, Roubini; Ansari, Jawaher; Landmesser, Johannes; Mollica, Veronica; Porta, Camillo; Bellmunt, Joaquim; Salah, Samer; Santini, Daniele, Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study, «CLINICAL AND EXPERIMENTAL MEDICINE», 2023, 23, pp. 5413 - 5422 [articolo]Open Access
